Evaluation of causative pathogens of pneumonia (HCAP) using bacterial floral analysis
Not Applicable
Completed
- Conditions
- Health Care Associated pneumonia
- Registration Number
- JPRN-UMIN000011838
- Lead Sponsor
- Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are going to be excluded due to the safety issues 2.Patients deemed ineligible by the attending physicians for various reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie bacterial flora changes in HCAP patients as studied in JPRN-UMIN000011838?
How does bacterial flora analysis in JPRN-UMIN000011838 compare to traditional diagnostic methods for HCAP causative pathogens?
What biomarkers are associated with HCAP pathogen identification through bacterial flora analysis in this trial?
Are there specific adverse events reported in HCAP observational studies using bacterial flora analysis?
What are the implications of JPRN-UMIN000011838 findings on HCAP management compared to other pneumonia trials?